Eric Padron

Hematology | Oncology

12902 Usf Magnolia Dr
Tampa, FL 33612

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 267 publications

Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution.

Prognostic Score for Myelodysplastic Syndromes Based on Molecular Evolution.

Journal: NEJM evidence

Published: May 26, 2026

Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia.

Cardiovascular Adverse Events During Venetoclax-Based Treatment in Acute Myeloid Leukemia.

Journal: Journal of the American Heart Association

Published: May 06, 2026

Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis.

Evaluating response criteria in myelodysplastic/myeloproliferative neoplasms: a systematic review and meta-analysis.

Journal: Blood neoplasia

Published: April 22, 2026

Single-cell RNA editing identifies aggressive and favorable cellular states in chronic myelomonocytic leukemia.

Single-cell RNA editing identifies aggressive and favorable cellular states in chronic myelomonocytic leukemia.

Journal: Haematologica

Published: April 03, 2026

Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024).

Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024).

Journal: Annals of hematology

Published: April 02, 2026

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 27, 2026

MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia.

MYST acetyltransferases are a targetable therapeutic vulnerability in SETBP1-mutant leukemia.

Journal: bioRxiv : the preprint server for biology

Published: January 16, 2026

Clinical and Genomic Convergence of High-Risk CCUS and Lower-Risk Myelodysplastic Syndromes/Neoplasms.

Clinical and Genomic Convergence of High-Risk CCUS and Lower-Risk Myelodysplastic Syndromes/Neoplasms.

Journal: Blood

Published: January 08, 2026

Myelodysplastic syndrome with concomitant SF3B1 mutation and deletion of chromosome 5 long arm: outcomes and response to treatment.

Myelodysplastic syndrome with concomitant SF3B1 mutation and deletion of chromosome 5 long arm: outcomes and response to treatment.

Journal: Haematologica

Published: December 18, 2025

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

Clinical, Genetic, and Pathologic Variability in Myelodysplastic Syndromes and Precursor Conditions Across Race, Ethnicity, and Sex.

Journal: American journal of hematology

Published: December 15, 2025

Exposure to Agent Orange and Association with Myelodysplastic Syndromes.

Exposure to Agent Orange and Association with Myelodysplastic Syndromes.

Journal: Blood advances

Published: December 01, 2025

Exposure to Agent Orange and association with myelodysplastic syndromes.

Exposure to Agent Orange and association with myelodysplastic syndromes.

Journal: Blood advances

Published: December 01, 2025

Showing 1-12 of 267

Last Updated: 09/26/2026